{"id":5116,"date":"2025-07-14T12:56:10","date_gmt":"2025-07-14T10:56:10","guid":{"rendered":"https:\/\/wp.vps-ccmiju.com\/webs\/ccmijesususon\/icts-nanbiosis\/"},"modified":"2026-02-02T18:36:34","modified_gmt":"2026-02-02T17:36:34","slug":"icts-nanbiosis","status":"publish","type":"page","link":"https:\/\/ccmijesususon.com\/en\/icts-nanbiosis\/","title":{"rendered":"ICTS – NANBIOSIS"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Integrated infrastructure for the production and characterization of nanomaterials, biomaterials, and systems in biomedicine (NANBIOSIS)<\/h2>

www.nanbiosis.es<\/a><\/strong><\/p>

Las Infraestructuras Cient\u00edficas y T\u00e9cnicas Singulares (ICTS)<\/a>, son instalaciones \u00fanicas y\u202fexcepcionales en su g\u00e9nero.\u202fEn ellas se\u202fdesarrollan\u202finvestigaciones de vanguardia y de m\u00e1xima calidad, y act\u00faan como\u202fcentros de transmisi\u00f3n, intercambio y preservaci\u00f3n del conocimiento, la transferencia de tecnolog\u00eda y el fomento de la innovaci\u00f3n. <\/p>

ICTS have three fundamental characteristics: they are publicly owned infrastructures, they are unique, and they are open to competitive access. <\/p>

The NANBIOSIS ICTS<\/a> is organized into five platforms: (1) biomolecule production; (2) biomaterial and nanomaterial production; (3) preclinical validation: characterization of tissues, biomaterials, and surfaces; (4) preclinical validation: bioimaging; and (5) high-performance computing. These platforms integrate 26 complementary and coordinated units located at different centers in Andalusia, Aragon, Catalonia, Galicia, Extremadura, Madrid, and the Basque Country. <\/p>

\"\"<\/a><\/figure><\/div>

Through a one-stop-shop system, NANBIOSIS provides integrated, tailor-made solutions to address the challenges faced by researchers in nanomedicine, medical diagnostics, and tissue engineering and regenerative medicine devices. These services include the design and production of bio-\/nanomaterials and their nanoconjugates, as well as the physicochemical, functional, toxicological, and biological characterization of these materials, tissues, and medical devices, up to in vivo preclinical validation. NANBIOSIS offers solutions across multiple application fields, and its configuration enables state-of-the-art multidisciplinary studies. <\/p>